Grant: CIHR Fellowship
Direct Payment
$87,500.00
The transcription factor network regulating Th17 lineage specification and function
FY 2009-10
Summary
T cells are a class of white blood cells that mediate immune responses against disease-causing bacteria, fungus, and viruses. A subcategory of T cells, termed T helper (Th)-17, that reside in the layers of the intestine wall are critical for fighting infections in the gut. However, abnormal reactions by Th17 cells result in chronic tissue inflammation and are thought to be involved in multiple human autoimmune diseases, including inflammatory bowel disease (IBD), multiple sclerosis, and arthritis. Efforts to treat disease by influencing the development or activity of Th17 cells will require a precise understanding of Th17 biology. The development of cells into different subtypes is a highly controlled process that is mediated by the action of transcription factors that regulate the expression of lineage-associated genes. To date, six transcription factors have been identified that are essential for various aspects of Th17 development and/or activity: ROR(gamma)t, STAT3, IRF-4, BATF, AHR, and Runx-1. The goals of this project are 1) to identify the direct gene targets of these factors in both developing and pathogenic (disease-inducing) Th17 cells; and 2) to understand how these factors cooperate to program Th17 lineage development and function. To achieve this, I will use biochemical approaches to identify genes that are directly bound by each factor in mouse Th17 cells. This will be followed by computational analysis to generate a detailed map of the interaction between factors, thus describing co-regulated genes and identifying cellular pathways important to the Th17 lineage. This information will provide valuable insight into how the differentiation of Th17 cells may be therapeutically manipulated, and in turn, open up new avenues for the treatment of IBD and other inflammatory diseases that have been reported to involve pathogenic Th17 responses.
Department
Program
CIHR Fellowship
Recipient
Location
New York, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
203527
Name
Ciofani Maria
Region
New York
Country
United States of America
Orgtype
Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
The transcription factor network regulating Th17 lineage specification and function
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$87,500
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Bioinformatics; Chromatin Immunoprecipitation; Epigenetics And Chromatin; Gene Expression; High Throughput Sequencing Technologies; Inflammation; Rorgamma(T); T Cell Specification; T Helper 17 (Th17) Lineage; Transcriptional Regulation
Abstract
T cells are a class of white blood cells that mediate immune responses against disease-causing bacteria, fungus, and viruses. A subcategory of T cells, termed T helper (Th)-17, that reside in the layers of the intestine wall are critical for fighting infections in the gut. However, abnormal reactions by Th17 cells result in chronic tissue inflammation and are thought to be involved in multiple human autoimmune diseases, including inflammatory bowel disease (IBD), multiple sclerosis, and arthritis. Efforts to treat disease by influencing the development or activity of Th17 cells will require a precise understanding of Th17 biology. The development of cells into different subtypes is a highly controlled process that is mediated by the action of transcription factors that regulate the expression of lineage-associated genes. To date, six transcription factors have been identified that are essential for various aspects of Th17 development and/or activity: ROR(gamma)t, STAT3, IRF-4, BATF, AHR, and Runx-1. The goals of this project are 1) to identify the direct gene targets of these factors in both developing and pathogenic (disease-inducing) Th17 cells; and 2) to understand how these factors cooperate to program Th17 lineage development and function. To achieve this, I will use biochemical approaches to identify genes that are directly bound by each factor in mouse Th17 cells. This will be followed by computational analysis to generate a detailed map of the interaction between factors, thus describing co-regulated genes and identifying cellular pathways important to the Th17 lineage. This information will provide valuable insight into how the differentiation of Th17 cells may be therapeutically manipulated, and in turn, open up new avenues for the treatment of IBD and other inflammatory diseases that have been reported to involve pathogenic Th17 responses.
Competitiondate
201002
Approvedterm2
1 yr 9 mths
Pinamesdelim
Ciofani, Maria
Approvedterm
1 an 9 mois
Cihrcontribution2
~ $87,500~ $0~